The Wien Center for Alzheimer’s Disease and Memory Disorders at Mount Sinai Medical Center will host a free, interactive webinar to discuss preventive treatments for Alzheimer’s disease. The online symposium will take place on Friday, November 30th at 1:00PM. The forum should be of special interest to individuals who are at risk of developing Alzheimer’s or who have family members with memory- related concerns.
The webinar will feature a panel discussion with three international experts in Alzheimer’s disease: Dr. Jessica Langbaum, research scientist with the Banner Alzheimer’s Institute and Associate Director of the Alzheimer’s Prevention Initiative; Dr. Andy Saykin, Director of Indiana University’s Center for Neuroimaging; and Dr. Susan Landau, research scientist at the Helen Wills Neuroscience Institute at the University of California, Berkeley. The experts will discuss symptoms of Alzheimer’s, why effective treatment needs to begin early and clinical trials set to begin in 2013 that will examine prevention of the disease. Participants will also have an opportunity to participate in an ample question and answer session.
Dr. Ranjan Duara, Director of The Mount Sinai Wien Center for Alzheimer’s Disease and Memory Disorders will host and moderate the event. “Part of our discussions at this symposium will be about how we can determine when the disease in its earliest stages, just like we detect high cholesterol in people’s blood and start treating high cholesterol whether or not patients have any symptoms. The same goes for treating Alzheimer’s early so we can prevent the disease from escalating.
“ The webinar is a pre-cursor to the 11th annual Mild Cognitive Impairment (MCI) Symposium to be held on Miami Beach in January. International experts in the fields of neurology, neuropsychology, psychiatry, geriatrics and neuropathology will gather to explore risk factors, diagnosis and progression of Alzheimer’s, and aims to provide a forum for new information and in-depth discussions about advances in research related to the clinical diagnosis and progression of the disease.
Unless ways are found to prevent Alzheimer’s disease or delay its onset, it is projected that 13 million people in the U.S. will have Alzheimer’s Disease by 2050. Since the development of criteria for the disease twenty-five years ago, major advances in our understanding of the biology and early clinical features of Alzheimer’s have led to improvement in clinical assessments which have enabled clinicians to diagnose an earlier stage of the illness.
To register for this free webinar taking place at 1:00 p.m. on Friday, November 30th, visit www.mcisymposium.org/webinar. For more information on Mount Sinai’s Wien Center for Alzheimer’s Disease and Memory Disorders, call 305- 674-CARE (2273).